RetiSpec and Gentex are partnering to develop a technology to detect Alzheimer’s disease — potentially years before…
Articles by David Melamed, PhD
A first patient has been dosed in a Phase 2 trial investigating the safety and long-term efficacy of bryostatin-1 in…
GemVax & KAEL has filed for expanded access of its U.S. Food and Drug Administration (FDA)…
Cortexyme has reached a milestone after enrolling 500 patients with mild to moderate Alzheimer’s disease in its ongoing…
AC Immune is planning to advance its investigational anti-TDP-43 antibody into clinical testing for neurodegenerative diseases…
The U.S. Food and Drug Administration (FDA) has accepted a request by Acadia Pharmaceuticals‘ that  Nuplazid (pimavanserin) be…